Skip to main content

Technological Innovation - A Prime Aggregator In The Calorie Reduction Ingredients Market

Human consumes too many calories on a steady basis. This increases the chances of becoming obese and overweight, which is a primary cause of early death and poor health. Reducing calories means either to remove or replace carbohydrates or fats. On the baker's end goal the replacement or removal takes place. Calorie reduction ingredients are used to lower the calorie level in the food products without altering the taste of the products.
To make numerous low calorie and low-fat foods, low-calorie ingredients are used. Low-calorie ingredients are used to manufacture good tasting and low-calorie food products. A large variety of low-calorie ingredients available and they are allowing food manufacturer to choose the most appropriate ingredient or combination of ingredients to produce more healthy and low-calorie food products.

Calorie Reduction Ingredients and its Properties:

Calorie reduction ingredients replace the high-calorie food ingredients present in the food products. Calorie reduction ingredients lower down the level of calories present in the food products without altering the taste, flavor, and texture of the food and beverage products. Calorie reduction ingredients contain fewer calories than sugars and flours while being able to imitate a few of the functionality these ingredients bring to a preparation. Calorie reduction ingredients provide the same functions such as taste, structure, and mouthfeel as sugar, fat, and flour provide.

Calorie reduction ingredients such as insoluble fibers work better in variety of application where less water absorption needed and soluble fibers are used where the higher water absorption is required. Products such as sugar alcohols or polyols can be used as a replacement for sugar in food and beverages, where the textural component lost when sugar is removed.


Calorie Reduction Ingredients Market: Market Dynamics

Reduced-calorie and reduced-fat food and beverage products do not substitute a need for overall good nutrition and moderation. Though, calorie reduction ingredients deliver delicious alternatives which make the challenging task of reducing calories and fat in the diet simpler. Calorie reduction ingredients can positively contribute to a healthy lifestyle when used in a balanced nutritional diet.

With increased knowledge about technology and taste, the food and beverage industry is on the edge of improving a broader variety of low-calorie, low-fat products, and good-tasting to cater the increasing demands and needs of consumers. Consumer interest is increasing in calorie reduction ingredients market to enjoy the favorite food and beverages with the same taste and high quality, with better management of weight. 

Calorie Reduction Ingredients Market: Segmentation

On the basis of the End Use, the global Single Calorie Reduction Ingredients market has been segmented as:
  • Dairy Products
  • Cereals, Grains, and Pasta
  • Meat, Fish, and Poultry
  • Baked Goods
  • Others
On the basis of ingredient type, the global Calorie Reduction Ingredients market has been segmented as:
  • Saccharin and Cyclamate
  • Aspartame
  • Acesulfame Potassium
  • Sucralose
  • Neotame
  • Polyols
On the basis of Geographical area, the global Calorie Reduction Ingredients market has been segmented as:
  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East & Africa
Get To Know Methodology of This Report @ https://www.persistencemarketresearch.com/methodology/30257

Calorie Reduction Ingredients Market: Market Participants

Some of the market participants dominating the global Calorie Reduction Ingredients market identified across the value chain include Tate & Lyle, Rainbow Rich Industrial Limited, PT. BATANG ALUM INDUSTRIE, HYET Sweet, SinoSweet Co., Ltd., Van Wankum Ingredients, Viachem, Ltd., Prinova Group LLC, Celanese Corporation, JK Sucralose Inc., Techno Food Ingredients Co., Nantong Changhai Food Additive Co. Ltd., and Cargill Incorporated among the other Calorie Reduction Ingredients manufacturers across the world.

Opportunities for Participants in the Calorie Reduction Ingredients Market

Increasing obesity and health issues due to increased calorie intake demanding more calorie reduction ingredients. Increasing awareness about the negative impact of increased calorie consumption leads to an increase in the demand for calorie reduction ingredients. Manufacturers of food and beverages seeking for the variety of calorie reduction ingredients that helps to provide the low-calorie food and beverages products, this helps in the growth of the calorie reduction ingredients market across the globe. Calorie reduction ingredients help to meet the nutrition level, health, and wellness needs without altering the taste and flavor of the food and beverages, which increases the demand for calorie reduction ingredients globally.

Top Market Insights

The Insulin Delivery Device Market To Show Constructive Disruption With US$ 14.09 Billion

Persistence Market Research Released New Market Report on “Global Market Study on Insulin Delivery Devices - Asia to Witness Highest Growth by 2020” the global insulin delivery devices market is estimated at USD 9,391.1 million in 2014 and is expected to grow at a  CAGR of 7%  from 2014 to 2020, to reach an estimated value of  USD 14,093.3 million in 2020 . The insulin delivery devices market is witnessing a significant growth due to the increasing prevalence of diabetes and rising obese endemic. In addition, advanced features of insulin delivery devices and rising awareness among people about diabetes care are also supporting in the growth of the global insulin delivery devices market. Get Going With Sample Of Insulin Delivery Device Market Report!  https://www.persistencemarketresearch.co/samples/2823 Some of the major players operating in the market: Abbott Laboratories. Novo Nordisk A/S. Eli Lilly and Company. Medtronic, Inc. Sanofi, Becton. Dickinson and Company...

The Bioinformatics Market To Grow Inadvertently

The Bioinformatics Market is bound to grow vigorously in the next 10 years. IoT has already made a beeline to the healthcare vertical. This has, in turn, enabled tracking of real-time locations of the apparatus and medical devices like scales, wheelchairs, defibrillators, or nebulizers along with remote monitoring. The entire healthcare vertical is expected to run on the IoT wave going forward.   The global  bioinformatics market  is exhibiting a  20.40% CAGR  from 2014 to 2020, according to a new market study recently released by Persistence Market Research. The market was calculated to be worth  US$4.1 bn  in 2014 and is estimated to reach  US$12.5 bn  by 2020, says PMR’s report, titled ‘ Global Market Study on Bioinformatics – Asia to Witness Fastest Growth by 2020 ’.   Get Going With Sample Of Bioinformatics Market Report!  https://www.persistencemarketresearch.com/samples/2778   The bioinformatics market is drive...

The Next 10 Years To Witness Formidable Growth Of Hospital Acquired Pneumonia Prevention Market (CAGR Of 4.7%) Between 2026

  The   Hospital Acquired Pneumonia Prevention Market Share   is estimated to be reaching   US$ 1,100 Million   at a   CAGR of 4.7%   from   2026 . With advanced digitization driving the healthcare industry, the concept of a “global village” has become a reality. As such, medical treatment could be sought to transcend the geographical barriers, which would form the focal point of the healthcare industry going forward. Over an eight-year period of assessment 2018-2026, the global market for hospital-acquired pneumonia prevention is poised to witness moderate growth, according to a recent research report on the global  hospital-acquired pneumonia prevention market . The report has been published by Persistence Market Research and is titled, “Hospital-Acquired Pneumonia Prevention Market: Global Industry Analysis 2013 – 2017 and Forecast 2018 – 2026.” The  US$ 795 Mn  market is likely to exhibit a CAGR of 4.7%, reaching a value in exce...

The Next Decade To Sparkle With Acne Treatment Market Growing At The Rate Of 4.6% From 2025

  The   Acne Treatment Market Share   is estimated to be reaching   US$ 4,500 Million   at a   CAGR of 4.6%   from   2025 . With advanced digitization driving the healthcare industry, the concept of a “global village” has become a reality. As such, medical treatment could be sought to transcend the geographical barriers, which would form the focal point of the healthcare industry going forward. The average age of onset of acne has reduced from 14-15 years to 11-12 years due to changing demographics and social habits. Moreover, some of the misleading media content continue to encourage the habit of self-medication that often backfires, resulting in further complication. Over the past couple of years, demand for acne treatment drugs and medications has surged at a remarkable pace. After conducting an exclusive study, Persistence Market Research (PMR) identified that approximately 20% of the young population (aged below 13 years) suffer from moderate...

Sequential Advancements In Technology To Drive The Autogenous Vaccine For Aquaculture Market

  The   Autogenous Vaccine For Aquaculture Market Share  is expected to reach   US$ 11 Mn   between   2020 to 2030   at a   CAGR of 6% . Speedy development on the part of ICT does bring in new-fangled advantages like more autonomy to patients along with the promotion of interagency collaboration. As such, the ones with comorbidities and multidimensional problems would find themselves safe. This increased dependency is bound to drive the healthcare vertical going forward. Fish is a widely consumed food across the world. In 2019, 177.8 million metric tons of fish were produced globally. In spite of such huge production in aquaculture, bacterial disease is a major issue, and is causing multibillion-dollar losses annually. In developing countries, fish diseases often spread quickly between small-scale aquaculture farms. Rising prevalence of infectious diseases such as bacterial diseases, viral diseases, and parasitic and fungal diseases amongst fish s...

Opioids Market to Register CAGR 4.7% Increase in Revenue by 2021 End

  Persistence Market Research (PMR) delivers key insights on the Global   Opioids Market   in its latest report titled “Global Market Study on Opioids: Widespread Usage in Treatment of Cancer to Drive the Growth of Opioids Market During the Forecast Period ”.The global opioids market is anticipated to exhibit a stable CAGR during the forecast period (2015-2021). By product type, the global opioids market is segmented into morphine, codeine, fentanyl, meperidine and methadone. Morphine segment was the largest contributor in overall opioids market, accounting for around 36% share in 2014. However, fentanyl segment is expected to register fastest CAGR of 4.7% during the forecast period. Synthetic opioids such as fentanyl, meperidine and methadone have lucrative growth opportunities in opioids market, owing to their potential application in opioid substitution treatment and fewer side effects as compared to natural opioids. Get Sample Copy of Report @  https://www.persis...

The Perfusion Bioreactors Market Is Expected To Grow On An Irrevocable Not At The Rate Of 7.5% Between 2021-2031

  The   Ischemic Optic Neuropathy Treatment Market Share  is expected to reach   US$ 187.7 Mn   at the rate of   3.7%   from   2021-2031 . With effective remote monitoring, the healthcare vertical is onto the awareness-building spree, so that patients could get benefited out of these services, telehealth, in particular. As such, several informative landing pages could be seen about the remote monitoring software. Ischemic optic neuropathy occurs because of a small vessel infraction of the optic nerve, and is a significant reason for impaired vision or blindness. Increasing utilization of newly approved intravitreal implants for the treatment of optic nerve disorders is expected to drive the market over the coming years. With developing awareness toward eye-associated inconveniences that give rise to impaired vision, diabetic patients and the geriatric population in developed nations are believed to have a proactive methodology for treatment-associ...

The Organic Mode Of Expansion To Dictate The Terms Of Growth For Phenylketonuria Treatment Market At The Rate Of CAGR 7% Between 2020 to 2030

  The   Phenylketonuria Treatment Market Share   is estimated to be reaching   US$ 565.8 Mn   at a   CAGR of 7%   from   2020 to 2030 . With advanced digitization driving the healthcare industry, the concept of a “global village” has become a reality. As such, medical treatment could be sought to transcend the geographical barriers, which would form the focal point of the healthcare industry going forward. Phenylketonuria (PKU) is an inherited disorder caused by excess of phenylalanine in the blood, which can lead to severe intellectual disabilities. There is no cure for phenylketonuria as yet, and dietary management is the only option to maintain the phenylalanine level in the body. Untreated infants with PKU tend to have unusually light eye, skin, and hair colour due to excess of phenylalanine levels interfering with melanin. Neurological symptoms such as seizures, abnormal muscle movement, tremors, or involuntary movement are some of the sympto...

Geographical Expansion To Catalyze The HPMC Capsules Market (US$ 120 Million) From 2025

  The   Global HPMC Capsules Market Share  is expected to reach   US$ 120 Million   at a CAGR of   10.9%   between   2025 . With “brand building” taking the center stage, the healthcare vertical would also be vying for brand building. In other words, increased visibility online would help the healthcare marketing service providers in making greater strides with regards to patient experience, right from drugs to treatment. HPMC capsules are strictly non-toxic and qualify to be Kosher and Halal-certified, which is why their popularity has grown in several parts of the world. Moreover, these capsules can significantly boost the body metabolism by improving absorption and digestion of protein, fat and carbohydrates. HPMC capsules find their application in the preparation of non-animal based medicines and cosmetics & nutraceuticals products. Persistence Market Research (PMR) recently conducted a study on the  global HPMC capsules market ...

The Peripheral Intravenous Catheter Market Is Expected To Grow On An Irrevocable Not At The Rate Of 7% Between 2019 to 2029

The  Global Peripheral Intravenous Catheter Market Share  is expected to reach  US$ 4.9 Billion  at a CAGR of  7%  between  2019 to 2029 . With “brand building” taking the center stage, the healthcare vertical would also be vying for brand building. In other words, increased visibility online would help the healthcare marketing service providers in making greater strides with regards to patient experience, right from drugs to treatment. Increasing hospitalizations, anticipated rise in cancer incidence, and higher demand for infused chemotherapy agents are fuelling the need for higher quality catheters for safe usage. Furthermore, rising number of biologic approvals is increasing the demand for infusion therapies. The global peripheral intravenous catheters market was valued at  US$ 4.9 Bn  in  2020 , and is expected to witness a healthy  CAGR of 7%  during the forecast period ( 2020 – 2030 ). Strategizi...